The comparative antimicrobial activity of levofloxacin tested against 350 clinical isolates of streptococci

Diagnostic Microbiology and Infectious Disease

Volumn 25, Issue 1, 1996, Pages 47-51

  Biedenbach, Douglas J ^a   Jones, Ronald N ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; CEFOTAXIME; CEFTAZIDIME; CEFTIZOXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; ERYTHROMYCIN; GENTAMICIN; LEVOFLOXACIN; OFLOXACIN; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATION; DRUG BIOAVAILABILITY; MINIMUM INHIBITORY CONCENTRATION; PENICILLIN RESISTANCE; PRIORITY JOURNAL; STRAIN DIFFERENCE; STREPTOCOCCUS; STREPTOCOCCUS INFECTION;

EID: 0030152390     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/0732-8893(96)00066-1     Document Type: Article

References (16)

1. Alcaide F, Linares J, Pallares R, Carratala J, Benitez MA, Gudiol F, Martin R (1995) In vitro activities of 22 β-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood. Antimicrob Agents Chemother 39:2243-2247.
2. Appelbaum PC (1992) Antibiotic resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis 15:77-83.
3. Betriu C, Gomez M, Sanchez A, Cruceyra A, Romero J, Picazo JJ (1994) Antibiotic resistance and penicillin tolerance in clinical isolates of group G streptococci. Antimicrob Agents Chemother 38:2183-2186.
4. Cercenado E, Diaz MD, Sanchez-Carrillo C, Vicente T, Bernaldo de Quiros JCL (1995) Enhanced activity of the combination of penicillin G and gentamicin against penicillin-resistant viridans group streptococci. Antimicrob Agents Chemother 39:2816-2818.
5. Cormican MG, Erwin ME, Jones RN (1995) Bactericidal activity of cefotaxime, desacetylcefotaxime, rifampin, and various combinations tested at cerebrospinal fluid levels against penicillin-resistant Streptococcus pneumoniae. Diagn Microbiol Infect Dis 22:119-123.
6. Fu KP, Lafredo SC, Foleno B, Isaacson DM, Barrett JF, Tobia AJ, Rosenthale ME (1992) In vitro and in vivo antibacterial activities of levofloxacin (L-ofloxacin), an optically active ofloxacin. Antimicrob Agents Chemother 36: 860-868.
7. Gehanno P, Lenoir G, Berche P (1995) In vivo correlates for Streptococcus pneumoniae penicillin resistance in acute otitis media. Antimicrob Agents Chemother 39:271-272.
8. Jacobs JA, Stobberingh EE (1996) In vitro antimicrobial susceptibility of the Streptococcus milleri group (Streptococcus anginosus, Streptococcus constellatus and Streptococcus intermedius). J Antimicrob Chemother 37:371-375.
9. Jones RN, Kehrberg EN, Erwin ME, Anderson SC, the Fluoroquinolone Resistance Surveillance Group (1994) Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States. I. Study on the threat of emerging resistances: Real or perceived? Diagn Microbiol Infect Dis 19:203-215.
10. National Committee for Clinical Laboratory Standards (NCCLS) (1993) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard M7-A3. 3rd ed. Villanova, PA: NCCLS.
11. National Committee for Clinical Laboratory Standards (NCCLS) (1995) Performance standards for antimicrobial susceptibility testing: sixth informational supplement M100-S6. Villanova, PA: NCCLS.
12. Paris MM, Ramilo O, McCracken GH Jr (1995) Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae. Antimicrob Agents Chemother 39: 2171-2175.
13. Plouffe JF, Franklin County Pneumonia Study Group (1996) Levofloxacin in vitro activity against bacteremic isolates of Streptococcus pneumoniae. Diagn Microbiol Infect Dis (in press).
14. Sutton LD, Jones RN (1995) Suggested modifications for disk diffusion susceptibility testing criteria for levofloxacin and sparfloxacin following tests with a predictor panel of ciprofloxacin-resistant clinical isolates. J Clin Microbiol 33:146-148.
15. Viladrich PF, Cabellow C, Pallares R, Tubau F, Martinez-Lacasa J, Linares J, Gudiol F (1996) High doses of cefotaxime in treatment of adult meningitis due to Streptococcus pneumoniae with decreased susceptibilities to broad-spectrum cephalosporins. Antimicrob Agents Chemother 40:218-220.
16. Wise R, Child J, Mortiboy D, Chow A (1995) An open-label, cross-over study of the pharmacokinetics and tissue penetration of two dose regimens of levofloxacin [abst A54]. In Abstracts of the 35th Interscience Conference of Antimicrobial Agents and Chemotherapy, San Francisco, CA.